Johns Hopkins Medicine: Scientists Identify New Epigenetic Approach to Target Colorectal Cancer
January 16, 2025
January 16, 2025
BALTIMORE, Maryland, Jan. 16 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new study from researchers at the Johns Hopkins Kimmel Cancer Center and the Chinese Academy of Sciences.
In the study, published Jan. 8 in the journal Nature Communications, the mou . . .
A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new study from researchers at the Johns Hopkins Kimmel Cancer Center and the Chinese Academy of Sciences.
In the study, published Jan. 8 in the journal Nature Communications, the mou . . .